Emery P - Search Results

1

Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study.

Smolen JS, Pangan AL, Emery P, Rigby W, Tanaka Y, Vargas JI, Zhang Y, Damjanov N, Friedman A, Othman AA, Camp HS, Cohen S. Smolen JS, et al. Among authors: emery p. Lancet. 2019 Jun 8;393(10188):2303-2311. doi: 10.1016/S0140-6736(19)30419-2. Epub 2019 May 23. Lancet. 2019. PMID: 31130260 Free article. Clinical Trial.

2

Generalised bone loss in patients with early rheumatoid arthritis.

Gough AK, Lilley J, Eyre S, Holder RL, Emery P. Gough AK, et al. Among authors: emery p. Lancet. 1994 Jul 2;344(8914):23-7. doi: 10.1016/s0140-6736(94)91049-9. Lancet. 1994. PMID: 7912297

3

Clinical use of cyclosporin in rheumatoid arthritis.

Richardson C, Emery P. Richardson C, et al. Among authors: emery p. Drugs. 1995;50 Suppl 1:26-36. doi: 10.2165/00003495-199500501-00005. Drugs. 1995. PMID: 8714796 Review.

4

The acute phase and function in early rheumatoid arthritis. C-reactive protein levels correlate with functional outcome.

Devlin J, Gough A, Huissoon A, Perkins P, Holder R, Reece R, Arthur V, Emery P. Devlin J, et al. Among authors: emery p. J Rheumatol. 1997 Jan;24(1):9-13. J Rheumatol. 1997. PMID: 9002004

5

Rheumatoid arthritis: not yet curable with early intensive therapy.

Emery P. Emery P. Lancet. 1997 Aug 2;350(9074):304-5. doi: 10.1016/S0140-6736(97)22031-3. Lancet. 1997. PMID: 9251629 No abstract available.

6

Classification of inflammatory arthritis by enthesitis.

McGonagle D, Gibbon W, Emery P. McGonagle D, et al. Among authors: emery p. Lancet. 1998 Oct 3;352(9134):1137-40. doi: 10.1016/S0140-6736(97)12004-9. Lancet. 1998. PMID: 9798608 Review.

7

Issues in rheumatoid arthritis.

Emery P, Smolen J. Emery P, et al. Lancet. 1999 Apr 3;353(9159):1186. doi: 10.1016/S0140-6736(05)74407-X. Lancet. 1999. PMID: 10210007 No abstract available.

8

Does the age of onset of rheumatoid arthritis influence phenotype?: a prospective study of outcome and prognostic factors.

Pease CT, Bhakta BB, Devlin J, Emery P. Pease CT, et al. Among authors: emery p. Rheumatology (Oxford). 1999 Mar;38(3):228-34. doi: 10.1093/rheumatology/38.3.228. Rheumatology (Oxford). 1999. PMID: 10325661

9

Persistence of mild, early inflammatory arthritis: the importance of disease duration, rheumatoid factor, and the shared epitope.

Green M, Marzo-Ortega H, McGonagle D, Wakefield R, Proudman S, Conaghan P, Gooi J, Emery P. Green M, et al. Among authors: emery p. Arthritis Rheum. 1999 Oct;42(10):2184-8. doi: 10.1002/1529-0131(199910)42:10<2184::AID-ANR20>3.0.CO;2-2. Arthritis Rheum. 1999. PMID: 10524691 Free article.

10

Access to disease modifying treatments for rheumatoid arthritis patients.

Furst DE, Breedveld FC, Burmester GR, Crofford L, Emery P, Feldman M, Kalden JR, Kavanaugh A, Keystone E, Lipsky PE, Maini RN, Moreland L, Smolen JS, Van De Putte L, Vischer T, Weinblatt M, Weissman M. Furst DE, et al. Among authors: emery p. Ann Rheum Dis. 1999 Nov;58 Suppl 1(Suppl 1):I129-30. doi: 10.1136/ard.58.2008.i129. Ann Rheum Dis. 1999. PMID: 10577989 Free PMC article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,437 results

Search Page

Filters